Clinical Trial

A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease

Name: A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease — clinical trial record (NCT07078955)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of BRM421 Ophthalmic Solution compared to artificial tear for treatment of the signs and symptoms of dry eye disease (DED)

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-07-14; most recent amendment 2025-10-16.

Trial Details

NCT Number	NCT07078955
Lead Sponsor	BRIM Biotechnology Inc.
Conditions	Dry Eye Disease (DED), Keratoconjunctivitis Sicca
Enrollment	99 participants
Start Date	2025-12
Primary Completion	2026-11 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2025-10-20